NIAID Goes Dark on Infectious Disease Trial Funding
Published Date: 4/3/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed video meeting on May 1, 2025, to review important grant applications for clinical trials. This meeting affects researchers seeking funding and keeps sensitive info private. It helps decide who gets money to fight infectious diseases and supports exciting new medical research.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
Closed review decides clinical trial funding
If you are a researcher applying for the NIAID Clinical Trial Implementation Cooperative Agreement (U01, clinical trial required), a closed video meeting on May 1, 2025, from 11:00 a.m. to 1:00 p.m. will review and evaluate grant applications. That meeting helps decide who receives funding for infectious disease clinical trials.
Confidential handling of grant application details
The meeting will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, patentable material, and personal information in grant applications. This keeps sensitive technical ideas and personal data private during the May 1, 2025 review.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
Previous / Next Documents
Previous: 2025-05726, Noise Compatibility Program for Laredo International Airport, Webb County, Texas
The City of Laredo has submitted a plan to reduce noise around Laredo International Airport, and the FAA started reviewing it on March 31, 2025. This plan aims to make neighborhoods quieter by managing how land near the airport is used. The public can share their thoughts until June 2, 2025, and the FAA will decide within 180 days whether to approve the plan, which could affect local homes and businesses.
Next: 2025-05728, National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 28, 2025, to review special grant applications focused on training in data science for infectious and immune diseases. This meeting affects researchers applying for these grants and helps decide who gets funding to boost important scientific training. The meeting is private to protect sensitive information and will be held via video.